missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Human CD37 Antibody, R&D Systems™
Mouse Monoclonal Antibody
Marca: R&D Systems MAB4625
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with NS0 cells transfected with human CD37 (Accession Q96LM7). The IgG fraction of the tissue culture supernatant was purified by Protein G affinity chromatography.
CD37 Monoclonal specifically detects CD37 in Human samples. It is validated for Flow Cytometry, CyTOF-ready.
Especificaciones
| CD37 | |
| Monoclonal | |
| LYOPH | |
| Flow Cytometry 0.25 ug/10^6 cells, CyTOF-ready | |
| Q96LM7 | |
| CD37 | |
| Mouse myeloma cell line NS0-derived recombinant human CD37 Accession # Q96LM7 | |
| 100 μg | |
| Primary | |
| Detects human CD37. Stains human CD37 transfectants but not irrelevant transfectants. | |
| Human | |
| Purified |
| Flow Cytometry, CyTOF | |
| 424925 | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
| CD37, CD37 antigentetraspanin-26, CD37 molecule, cell differentiation antigen 37, GP52-40, leukocyte antigen CD37, MGC120234, Tetraspanin-26, Tspan-26, TSPAN26, TSPAN26leukocyte surface antigen CD37 | |
| Mouse | |
| Protein A or G purified from hybridoma culture supernatant | |
| RUO | |
| 951 | |
| Reconstitute at 0.5 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
| IgG2a |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido